DE60318706D1 - Marker für stammzellen und dessen verwendung - Google Patents

Marker für stammzellen und dessen verwendung

Info

Publication number
DE60318706D1
DE60318706D1 DE60318706T DE60318706T DE60318706D1 DE 60318706 D1 DE60318706 D1 DE 60318706D1 DE 60318706 T DE60318706 T DE 60318706T DE 60318706 T DE60318706 T DE 60318706T DE 60318706 D1 DE60318706 D1 DE 60318706D1
Authority
DE
Germany
Prior art keywords
msc
stem cells
marker
markers
mammalian
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60318706T
Other languages
English (en)
Other versions
DE60318706T2 (de
Inventor
Evy Lundgren-Akerlund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cartela R&D AB
Original Assignee
Cartela AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0201831A external-priority patent/SE0201831D0/xx
Application filed by Cartela AB filed Critical Cartela AB
Publication of DE60318706D1 publication Critical patent/DE60318706D1/de
Application granted granted Critical
Publication of DE60318706T2 publication Critical patent/DE60318706T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/7055—Integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
DE60318706T 2002-06-14 2003-06-12 Marker für stammzellen und dessen verwendung Expired - Lifetime DE60318706T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38829802P 2002-06-14 2002-06-14
SE0201831A SE0201831D0 (sv) 2002-06-14 2002-06-14 Marker for stem cells and its use
SE0201831 2002-06-14
US388298P 2002-06-14
PCT/SE2003/000983 WO2003106492A1 (en) 2002-06-14 2003-06-12 Marker for stem cells and its use

Publications (2)

Publication Number Publication Date
DE60318706D1 true DE60318706D1 (de) 2008-03-06
DE60318706T2 DE60318706T2 (de) 2009-04-30

Family

ID=29738561

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60318706T Expired - Lifetime DE60318706T2 (de) 2002-06-14 2003-06-12 Marker für stammzellen und dessen verwendung

Country Status (10)

Country Link
US (2) US7749710B2 (de)
EP (2) EP1990350A1 (de)
JP (1) JP4399533B2 (de)
AT (1) ATE384079T1 (de)
AU (1) AU2003239016B2 (de)
CA (1) CA2489212C (de)
DE (1) DE60318706T2 (de)
DK (1) DK1513877T3 (de)
ES (1) ES2306876T3 (de)
WO (1) WO2003106492A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1068238T3 (da) 1998-04-02 2013-01-14 Xintela Ab Integrinheterodimer og subunit deraf
SE0301087D0 (sv) 2003-04-14 2003-04-14 Cartela Ab New monoclonal antibody
AU2004228605B2 (en) * 2003-04-14 2011-05-26 Xintela Ab New monoclonal antibody capable of binding integrin alpha 10 beta 1
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
ES2313805B1 (es) * 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
WO2006106823A1 (ja) * 2005-03-31 2006-10-12 Japan Science And Technology Agency 分子マーカーを用いた間葉系幹細胞の識別方法及びその利用
DE102006026191A1 (de) * 2006-05-26 2007-11-29 Eberhard-Karls-Universität Tübingen Universitätsklinikum Vorrichtung und Substanz zur Isolierung von mesenchymalen Stammzellen (MSC)
WO2008099561A1 (ja) * 2007-02-14 2008-08-21 Japan Science And Technology Agency 抗菌性ペプチドを用いた細胞増殖促進剤及び該細胞増殖促進剤を含有する無血清培地を用いる細胞増殖促進方法
JP5429755B2 (ja) * 2008-04-18 2014-02-26 国立大学法人名古屋大学 間葉系幹細胞およびその生産方法
EP2377542A4 (de) * 2009-01-15 2013-04-03 Corestem Co Ltd Pharmazeutische zusammensetzung zur behandlung der knochenerkrankung oder zur bekämpfung von entzündung, umfassend knorpelstammzellen als aktives prinzip
US20160000698A1 (en) * 2014-07-07 2016-01-07 Medipost Co., Ltd. Capability of small-sized stem cells to stimulate hair growth and use thereof
AU2016220535B2 (en) 2015-02-16 2021-05-27 Targinta Ab Detection and treatment of malignant tumours in the CNS
GB201604304D0 (en) 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
ES2908586T3 (es) 2016-08-17 2022-05-03 Xintela Ab Marcador para células madre neurales
LT3573630T (lt) * 2017-01-27 2021-05-25 Xintela Ab Kaulų ir kremzlių pažeidimų arba ligų prevencija ir gydymas
BR112020010079A2 (pt) * 2017-11-22 2020-11-03 Mesoblast International Sàrl composições celulares e métodos de tratamento i

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837539A (en) * 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US6200606B1 (en) 1996-01-16 2001-03-13 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration
US5965436A (en) * 1996-11-15 1999-10-12 Osiris Therapeutics, Inc. Method of isolating mesenchymal stem cells associated with isolated megakaryocytes by isolating megakaryocytes
DK1068238T3 (da) 1998-04-02 2013-01-14 Xintela Ab Integrinheterodimer og subunit deraf
SE9902056D0 (sv) 1999-06-03 1999-06-03 Active Biotech Ab An integrin heterodimer and an alpha subunit thereof
AU2003239030A1 (en) * 2002-06-17 2003-12-31 Cartela R & D Ab Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation
EP1996698A1 (de) * 2006-03-01 2008-12-03 Cartela R&D AB Expansion und differenzierung mesenchymaler stammzellen

Also Published As

Publication number Publication date
JP4399533B2 (ja) 2010-01-20
US8105791B2 (en) 2012-01-31
ATE384079T1 (de) 2008-02-15
US7749710B2 (en) 2010-07-06
AU2003239016B2 (en) 2007-09-20
JP2006511201A (ja) 2006-04-06
DK1513877T3 (da) 2008-06-02
AU2003239016A1 (en) 2003-12-31
WO2003106492A8 (en) 2005-05-19
WO2003106492A1 (en) 2003-12-24
US20050221327A1 (en) 2005-10-06
EP1513877B1 (de) 2008-01-16
ES2306876T3 (es) 2008-11-16
EP1990350A1 (de) 2008-11-12
CA2489212C (en) 2012-08-14
CA2489212A1 (en) 2003-12-24
EP1513877A1 (de) 2005-03-16
US20110033923A1 (en) 2011-02-10
DE60318706T2 (de) 2009-04-30

Similar Documents

Publication Publication Date Title
DE60318706D1 (de) Marker für stammzellen und dessen verwendung
DE69939945D1 (de) Verfahren zur isolierung von stammzellen
CY1108329T1 (el) Κυτταρικη καλλιεργεια
MX348414B (es) Poblaciones de celula madre de la placenta.
HUP0105052A2 (hu) Eljárások nukleinsav amplifikálására és szekvenálására
BR0210599A (pt) Uso de monóxido de carbono, método para manutenção de uma célula animal in vitro, artigo de manufatura, bem como meio celular estéril
BRPI0506474A (pt) sistema de tecido com células tronco não diferenciadas derivadas no limbus da córnea
IL189143A0 (en) Use of common ?? chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes
DE60028989D1 (de) Medium für die protein- und serumfreie zellkultur
WO2006127809A3 (en) Methods for expansion and analysis of cultured hematopoietic stem cells
BR0315435A (pt) Distribuição de vegf com base na célula
MXPA04007426A (es) Usos de citosina de mamifero; reactivos relacionados.
AU2019268061A1 (en) Placental stem cell populations
WO2004031343A3 (en) Human foreskin cells suitable for culturing stem cells
DK1495112T3 (da) Cellekulturmedium
DK1129444T3 (da) Selvklæbende etiketter og fremstilling deraf
DE69930660D1 (de) Zellen, kulturverfahren, und ihre verwendung in autologer transplantationstherapie
GB2398079A (en) Characterization and isolation of subsets of human embryonic stem cells (HES) and cells associated or derived therefrom
DK1644485T3 (da) Udskilte proteiner som markører for celledifferentiering
BRPI0403200A (pt) Método para recrescimento de células embriogênicas crioconservadas de conìferas
IL165250A0 (en) Methods of donor specific crossmatching
DE60313718D1 (de) Zusammensetzung zur Zellkultur, die Polyethylenglykol enthält
DE60217890D1 (de) Mastzellkulturen aus dem schwein und deren verwendungen
AU2003232724A1 (en) A novel biological cancer marker and methods for determining the cancerous or non-cancerous phenotype of cells
ATE408003T1 (de) Medium zur züchtung von tumorzellen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: HANSA MEDICAL AB, MALMOE, SE

8328 Change in the person/name/address of the agent

Representative=s name: GRAPE & SCHWARZENSTEINER, 80331 MUENCHEN

8327 Change in the person/name/address of the patent owner

Owner name: CARTELA R & D AB, MALMOE, SE